Matthew Anderer
Directeur/Membre du Conseil chez INNOVEREN SCIENTIFIC INC.
Postes actifs de Matthew Anderer
Sociétés | Poste | Début | Fin |
---|---|---|---|
INNOVEREN SCIENTIFIC INC. | Directeur/Membre du Conseil | 17/01/2022 | - |
Independent Dir/Board Member | 17/01/2022 | - |
Historique de carrière de Matthew Anderer
Anciens postes connus de Matthew Anderer
Sociétés | Poste | Début | Fin |
---|---|---|---|
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Directeur/Membre du Conseil | 01/11/2020 | 01/06/2021 |
US Air Force | Directeur/Membre du Conseil | 01/07/2012 | 01/06/2013 |
Formation de Matthew Anderer
Villanova University | Undergraduate Degree |
Air Command & Staff College | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
2 |
Opérationnelle
Director/Board Member | 3 |
Undergraduate Degree | 2 |
Independent Dir/Board Member | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 3 |
Government | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
INNOVEREN SCIENTIFIC INC. | Health Technology |
Entreprise privées | 2 |
---|---|
US Air Force | Government |
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Health Technology |
- Bourse
- Insiders
- Matthew Anderer
- Expérience